November 1, 2016

Petr Vaňhara Team

 

Contact | Research Interests | Grants | Team Members | Collaboration | Publications

 

Contact

RNDr. Petr Vaňhara, PhD

  • CONTACT ADDRESS: Kamenice 126/3 | building A1 | CZ-625 00 Brno | Czech Republic
  • EMAIL: pvanhara@med.muni.cz
  • TEL.: 00420 5 4949 7780
  • FAX: 00420 5 4949 1320


Research interests

  • Molecular responses to cell and tissue stress in developmental and cancer context
  • Advanced histological analysis

We are curious:

  • how normal and cancer cells exploit molecular machinery of endoplasmic reticulum and unfolded protein response to adapt to various forms of stress in tissue microenvironment
  • if the integrated stress response can be used for monitoring and prediction of outcome of cancer patients
  • how individual stress-associated proteins affect cancer cell phenotype

We use 

  • state-of-the-art microscopy, including live-cell imaging
  • range of molecular and histological methods and tools
  • animal facility, including ultrasound sonography and tumor volumometry

We develop techniques for:

  • cell profiling and phenotyping using mass spectrometry and chemometrics
  • mass spectrometry-assisted tissue analysis and diagnostics

For details see our publications

 

 


Grants

  • Role of TUSC3-mediated ER stress response in dissemination of ovarian cancer, supported by the Czech-BioImaging large RI project (LM2015062 funded by MEYS CR) (2017, PI)
  • ER stress response in aging and regeneration, supported by the Czech-BioImaging large RI project (LM2015062 funded by MEYS CR) (2017, PI)
  • Institutional support by Faculty of Medicne MU for junior researchers (2015, PI)
  • Centrosomal abnormalities in human pluripotent stem cells (Czech Science Foundation, 2015–present, member of the team)
  • Bioanalytical Cell and Tissue Authentication using Physical Chemistry Methods and Artificial Intelligence (Grant Agency of Masaryk University, 2013–2015, member of the team)
  • HistoPARK – Centre for analysis and modeling of tissues and organs (European Regional Fund, 2012–2015)
  • Molecular mechanisms of novel tumor markers in ovarian and prostate cancers (Ministry of Education, Youth and Sports of the Czech Republic, 2012-2013, co-PI)

Teaching grants

  • Reconstruction and scaling-up of educational collection of histological samples at the Department of Histology and Embryology FM MU (Developmental Fund of Masaryk University, 2017, PI)
  • Interactive cytological and histological atlas (Developmental Fund of Masaryk University, 2016, PI)

 

Awards

Journal of Cell Biology Poster Prize & ICCB Prague 2016 Best Poster Award

International Congress of Cell Biology, Prague, 2016

Kratochvilova et al. “ER Stress Modulates Senescence and EMT in Ovarian Surface Epithelium”

 

diplom-jcbdiplom-iccb

 

Prize of Czech Society for Analytical Cytometry for the best research publication in 2015

Kratochvilova K., et al. (2015) “Tumor suppressor candidate 3 (TUSC3) prevents the epithelial-to-mesenchymal transition and inhibits tumor growth by modulating the endoplasmic reticulum stress response in ovarian cancer cells”. Int J Cancer 137: 1330-1340.

katka_diplom

Team members

Mgr. Kateřina Vašíčková (Kratochvílová)

  • PhD Thesis (in Anatomy, Histology and Embryology): Role of cell stress in senescence and malignant transformation

Bc. Lukáš Moráň

  • Master thesis (in Biochemistry): Exogenous inducers of ER stress in human immortalized somatic and cancer cells

Anna Pernická


Collaboration

Our collaboration network includes both national and international laboratories

  • Dr. Karel Souček, Institute of Biophysics, Academy of Science of the Czech Republic
  • Dr. Pena-Mendez, University of La Laguna, Spain
  • prof. Victoria Salvado, University of Girona, Spain
  • prof. Tiziana Pivetta, University of Cagliari, Italy
  • Dr. Peter Horak, German Cancer Research Center (DKFZ), Heidelberg, Germany

Publications

2017

  • Vašíčková K, Horak P, Vaňhara  P. “TUSC3: functional duality of a cancer gene”. Cell Mol Life Sci., (2017).doi: 10.1007/s00018-017-2660-4.
  • Samadder P, Suchanková T, Hylse O, Khirsariya P, Nikulenkov F, Drápela S, Straková N, Vaňhara P, Vašíčková K, Kolářová H, Binó L, Bittová M, Ovesná P, Kollar P, Fedr R, Ešner M, Jaroš J, Hampl A, Krejčí L, Paruch K, Soucek K. “Synthesis and profiling of a novel potent selective inhibitor of CHK1 kinase possessing unusual N-trifluoromethylpyrazole pharmacophore resistant to metabolic N-dealkylation”. Mol Cancer Ther., (2017). doi: 10.1158/1535-7163.MCT-17-0018.
  • Kolarova, L., Prokes, L., Hampl, A., Vanhara, P., Havel, J. “Clusters of Monoisotopic Elements for Calibration in (TOF) Mass Spectrometry.” J. Am. Soc. Mass Spectrom. 28, no. 3 (2017): 419-427. doi: 10.1007/s13361-016-1567-x.
  • Petr Vaňhara, Miroslava Sedláčková, Irena Lauschová, Svatopluk Čech, Aleš Hampl. GUIDE to GENERAL HISTOLOGY and MICROSCOPIC ANATOMY. Masaryk University, 2017. ISBN 978-80-210-8453-7.

guide

2016

  • Kratochvílová, K., Moráň L., Paďourová, S., Stejskal, S., Tesařová, L., Šimara, P., Hampl, A., Koutná I., Vaňhara, P. “The Role of the Endoplasmic Reticulum Stress in Stemness, Pluripotency and Development.” Eur. J. Cell Biol. 95(3-5)(2016): 115-23. doi: 10.1016/j.ejcb.2016.02.002.
  • Valletta, E., Kucera, L., Prokes, L., Amato, F., Pivetta, T., Hampl, A., Havel J., Vanhara, P. “Multivariate Calibration Approach for Quantitative Determination of Cell-Line Cross Contamination by Intact Cell Mass Spectrometry and Artificial Neural Networks.” PLoS One 11, no. 1 (2016): e0147414.

2015

  • Kolářová, Lenka, Lukáš Kučera, Petr Vaňhara, Aleš Hampl and Josef Havel. “Use of Flower-Like Gold Nanoparticles in Time-of-Flight Mass Spectrometry.” Rapid Communications in Mass Spectrometry 29, no. 17 (2015): 1585-1595.
  • Kratochvilova, K., P. Horak, M. Esner, K. Soucek, D. Pils, M. Anees, E. Tomasich, F. Drafi, V. Jurtikova, A. Hampl, M. Krainer and P. Vanhara. “Tumor Suppressor Candidate 3 (Tusc3) Prevents the Epithelial-to-Mesenchymal Transition and Inhibits Tumor Growth by Modulating the Endoplasmic Reticulum Stress Response in Ovarian Cancer Cells.” Int J Cancer 137, no. 6 (2015): 1330-40.

2014

  • Rucka, Z., I. Koutna, L. Teasarova, M. Potesilova, S. Stejskal, P. Simara, P. Vanhara, J. Dolezel, V. Zvonicek, O. Coufal and I. Capov. “Intravenous Insulin Therapy During Lung Resection Does Not Affect Lung Function or Surfactant Proteins.” BMC Pulm Med 14, no. 1 (2014): 155.
  • Horak, P., E. Tomasich, P. Vanhara, K. Kratochvilova, M. Anees, M. Marhold, C. E. Lemberger, M. Gerschpacher, R. Horvat, M. Sibilia, D. Pils and M. Krainer. “Tusc3 Loss Alters the Er Stress Response and Accelerates Prostate Cancer Growth in Vivo.” Sci Rep 4,  (2014): 3739.
  • Houska, J., E. M. Pena-Mendez, J. R. Hernandez-Fernaud, E. Salido, A. Hampl, J. Havel and P. Vanhara. “Tissue Profiling by Nanogold-Mediated Mass Spectrometry and Artificial Neural Networks in the Mouse Model of Human Primary Hyperoxaluria 1.” Journal of Applied Biomedicine 12, no. 2 (2014): 119-125.
  • Kolarova, L., P. Vanhara, E.M. Pena-mendez, A. Hampl and J. Havel. “Tissue Visualization Mediated by Nanoparticles: From Tissue Staining to Mass Spectrometry Tissue Profiling and Imaging.” In Nanomedicine, edited by A. Seifalian, 468-82. Manchester, UK: One Central Press, 2014.
  • Anees, M., P. Horak, A. I. Schiefer, P. Vanhara, A. El-Gazzar, P. Perco, B. Kiesewetter, L. Mullauer, B. Streubel, M. Raderer and M. Krainer. “The Potential Evasion of Immune Surveillance in Malt Lymphoma by Dcr2-Mediated Upregulation of Nf-Kappab.” Leuk Lymphoma,  (2014): 1-24.

2013

  • Amato, F. , A. Lopez, EM. Pena-Mendez, P. Vanhara, A. Hampl and J. Havel. “Artificial Neural Networks in Medical Diagnosis ” J Appl Biomed 11, no. 2 (2013): 47-58.
  • Pernicová, Zuzana, Petr Vaňhara and Karel Souček. “Formation of Secretory Senescent Cells in Prostate Tumors: The Role of Androgen Receptor Activity and Cell Cycle Regulation.” In Tumor Dormancy, Quiescence, and Senescence, Volume 1, edited by M. A. Hayat, 1, 303-316: Springer Netherlands, 2013.
  • Pils, D., P. Horak, P. Vanhara, M. Anees, M. Petz, A. Alfanz, A. Gugerell, M. Wittinger, A. Gleiss, V. Auner, D. Tong, R. Zeillinger, E. I. Braicu, J. Sehouli and M. Krainer. “Methylation Status of Tusc3 Is a Prognostic Factor in Ovarian Cancer.” Cancer 119, no. 5 (2013): 946-54.
  • Rucka, Z., P. Vanhara, I. Koutna, L. Tesarova, M. Potesilova, S. Stejskal, P. Simara, J. Dolezel, V. Zvonicek, O. Coufal and I. Capov. “Differential Effects of Insulin and Dexamethasone on Pulmonary Surfactant-Associated Genes and Proteins in A549 and H441 Cells and Lung Tissue.” Int J Mol Med,  (2013).
  • Vanhara, P., P. Horak, D. Pils, M. Anees, M. Petz, W. Gregor, R. Zeillinger and M. Krainer. “Loss of the Oligosaccharyl Transferase Subunit Tusc3 Promotes Proliferation and Migration of Ovarian Cancer Cells.” Int J Oncol 42, no. 4 (2013): 1383-9.
  • Vaňhara, P. and P. Souček. “Mutual Cytokine Crosstalk between Colon Cancer Cells and Microenvironment Initiates Development of Distant Metastases.” JAK-STAT 2, no. 2 (2013): 1-4.

2012

  • Vanhara, P., A. Hampl, A. Kozubik and K. Soucek. “Growth/Differentiation Factor-15: Prostate Cancer Suppressor or Promoter?” Prostate Cancer Prostatic Dis 15, no. 4 (2012): 320-8.

2011

  • Wittinger, M., P. Vanhara, A. El-Gazzar, B. Savarese-Brenner, D. Pils, M. Anees, T. W. Grunt, M. Sibilia, M. Holcmann, R. Horvat, M. Schemper, R. Zeillinger, C. Schofer, H. Dolznig, P. Horak and M. Krainer. “Hvps37a Status Affects Prognosis and Cetuximab Sensitivity in Ovarian Cancer.” Clin Cancer Res 17, no. 24 (2011): 7816-27.
  • Kren, L., O. Slaby, K. Muckova, E. Lzicarova, M. Sova, V. Vybihal, T. Svoboda, et al. “Expression of Immune-Modulatory Molecules Hla-G and Hla-E by Tumor Cells in Glioblastomas: An Unexpected Prognostic Significance?”. Neuropathology 31, no. 2 (Apr 2011): 129-34.

2006-2010

  • Kren, L., K. Muckova, E. Lzicarova, M. Sova, V. Vybihal, T. Svoboda, P. Fadrus, et al. “Production of Immune-Modulatory Nonclassical Molecules Hla-G and Hla-E by Tumor Infiltrating Ameboid Microglia/Macrophages in Glioblastomas: A Role in Innate Immunity?”. J Neuroimmunol 220, no. 1-2 (Mar 30 2010): 131-5.
  • Navratilova, J., P. Jungova, P. Vanhara, J. Preisler, V. Kanicky, and J. Smarda. “Copper Ions Regulate Cytotoxicity of Disulfiram to Myeloid Leukemia Cells.” Int J Mol Med 24, no. 5 (Nov 2009): 661-70.
  • Pekar, S., and P. Vanhara. “Geographical Sexual Size Dimorphism in an Ant-Eating Spider, Zodarion Rubidum (Araneae : Zodariidae).” J Nat Hist 40, no. 21-22 (2006): 1343-50.
  • Vanhara, P., V. Bryja, V. Horvath, A. Kozubik, A. Hampl, and J. Smarda. “C-Jun Induces Apoptosis of Starved Bm2 Monoblasts by Activating Cyclin a-Cdk2.” Biochem Biophys Res Commun 353, no. 1 (Feb 2 2007): 92-7.
  • Vanhara, P., E. Lincova, A. Kozubik, P. Jurdic, K. Soucek, and J. Smarda. “Growth/Differentiation Factor-15 Inhibits Differentiation into Osteoclasts–a Novel Factor Involved in Control of Osteoclast Differentiation.” Differentiation 78, no. 4 (Nov 2009): 213-22.
  • Vanhara, P., and J. Smarda. “Jun: The Master Regulator in Healthy and Cancer Cells.” J Appl Biomed 4, no. 4 (2006): 163-70.
  • Vanhara P., Smarda J. “[Regulation of Osteoclast Activity: A New Approach in the Therapy of Bone Diseases].” Cas Lek Cesk 145, no. 8 (2006): 606-10.